Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Koru Medical Systems Inc (NQ: KRMD ) 2.270 -0.080 (-3.40%) Streaming Delayed Price Updated: 11:43 AM EDT, Jul 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 97,172 Open 2.390 Bid (Size) 2.260 (1) Ask (Size) 2.270 (1) Prev. Close 2.350 Today's Range 2.220 - 2.400 52wk Range 1.978 - 3.550 Shares Outstanding 45,764,225 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan Today 7:00 EDT From KORU Medical Systems, Inc. Via Business Wire Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion June 05, 2024 From KORU Medical Systems Via Business Wire Performance YTD -4.62% -4.62% 1 Month +7.08% +7.08% 3 Month -5.42% -5.42% 6 Month -4.62% -4.62% 1 Year -35.51% -35.51% More News Read More KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic June 04, 2024 From KORU Medical Systems, Inc. Via Business Wire Recap: KORU Medical Systems Q4 Earnings March 13, 2024 Via Benzinga Earnings Outlook For KORU Medical Systems March 12, 2024 Via Benzinga KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic May 14, 2024 From KORU Medical Systems, Inc. Via Business Wire KRMD Stock Earnings: KORU Medical Systems Beats EPS, Beats Revenue for Q1 2024 May 01, 2024 Via InvestorPlace KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth May 01, 2024 From KORU Medical Systems, Inc. Via Business Wire KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 April 17, 2024 From KORU Medical Systems Via Business Wire KORU Medical Systems Announces Successful Appeal in EU Notified Body Review April 11, 2024 From KORU Medical Systems, Inc. Via Business Wire The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness March 28, 2024 Via InvestorPlace KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference March 18, 2024 From KORU Medical Systems, Inc. Via Business Wire KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance March 13, 2024 From KORU Medical Systems, Inc. Via Business Wire Earnings Scheduled For March 13, 2024 March 13, 2024 Via Benzinga KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic March 11, 2024 From KORU Medical Systems, Inc. Via Business Wire KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin March 06, 2024 From KORU Medical Systems, Inc. Via Business Wire KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 February 21, 2024 From KORU Medical Systems Via Business Wire KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference November 29, 2023 From KORU Medical Systems Via Business Wire KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023 November 28, 2023 From KORU Medical Systems, Inc. Via Business Wire KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System November 08, 2023 From KORU Medical Systems, Inc. Via Business Wire KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer November 08, 2023 From KORU Medical Systems, Inc. Via Business Wire KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook November 08, 2023 From KORU Medical Systems, Inc. Via Business Wire KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes November 07, 2023 From KORU Medical Systems, Inc. Via Business Wire KORU Medical Systems to Participate in Upcoming Investor Conferences November 02, 2023 From KORU Medical Systems Via Business Wire KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023 October 25, 2023 From KORU Medical Systems Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
